These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 769951)

  • 21. Treatment of solid tumors and lymphomas with methyl-CCNU (NSC-95441): a phase II study.
    Firat D; Tekuzman G
    Cancer Chemother Rep; 1975; 59(5):1021-3. PubMed ID: 1106843
    [No Abstract]   [Full Text] [Related]  

  • 22. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
    Posey LE; Morgan LR
    Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methyl CCNU and adriamycin for patients with metastatic sarcomas: a Southwest Oncology Group study.
    Rivkin SE; Gottlieb JA; Thigpen T; El Mawla NG; Saiki J; Dixon DO
    Cancer; 1980 Aug; 46(3):446-51. PubMed ID: 7397620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy for mustard-resistant ovarian adenocarcinoma: a randomized trial for CCNU and methyl-CCNU.
    Omura G; DiSaia P; Blessing J; Boronow R; Hreshchyshyn M; Park R
    Cancer Treat Rep; 1977 Nov; 61(8):1533-5. PubMed ID: 922756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-Strep) in patients with disseminated pancreatic carcinoma.
    Sordillo PP; Magill GB
    Am J Clin Oncol; 1982 Jun; 5(3):277-9. PubMed ID: 6282110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease.
    Durant JR; Bartolucci A; Gams RA; Dorfman RF; Velez-Garcia E
    Cancer Treat Rep; 1976 Jun; 60(6):781-7. PubMed ID: 782700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion.
    Kane RC; Cashdollar MR; Bernath AM
    Cancer Treat Rep; 1978 Oct; 62(10):1521-5. PubMed ID: 709554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of advanced squamous carcinoma of the lung: cyclophosphamide vesus "COMB".
    Bodey GP; Lagakos SW; Gutierrez AC; Wilson HE; Selawry OS
    Cancer; 1977 Mar; 39(3):1026-31. PubMed ID: 71943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methyl-CCNU inclinical cancer therapy.
    Wasserman TH; Slavik M; Carter SK
    Cancer Treat Rev; 1974 Dec; 1(4):251-69. PubMed ID: 4377543
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.
    Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK
    Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.
    Maurice P; Glidewell O; Jacquillat C; Silver RT; Carey R; Pas AT; Cornell CJ; Burningham RA; Nissen NI; Holland JF
    Cancer; 1978 May; 41(5):1658-63. PubMed ID: 348294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostate.
    Loening SA; Scott WW; deKernion J; Gibbons RP; Johnson DE; Pontes JE; Prout GR; Schmidt JD; Soloway MS; Chu TM; Gaeta JF; Slack NH; Murphy GP
    J Urol; 1981 Jun; 125(6):812-6. PubMed ID: 7017170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results with methyl-CCNU and DTIC in metastatic melanoma.
    Costanza ME; Nathanson L; Schoenfeld D; Wolter J; Colsky J; Regelson W; Cunningham T; Sedransk N
    Cancer; 1977 Sep; 40(3):1010-5. PubMed ID: 332319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methyl-CCNU, alone and in combination with vincristine, or vincristine and methotrexate, in advanced bronchogenic carcinoma.
    Richards F; Cooper MR; Muss HB; White DR; Spurr CL
    Cancer; 1976 Sep; 38(3):1077-82. PubMed ID: 953956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined modality treatment for oat cell carcinoma of the lung: a randomized trial 1,2,3.
    Alexander M; Glatstein EJ; Gordon DS; Daniels JR
    Cancer Treat Rep; 1977; 61(1):1-6. PubMed ID: 193642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokinetic chemotherapy design for the treatment of advanced lung cancer.
    Straus MJ
    Cancer Treat Rep; 1979 May; 63(5):767-73. PubMed ID: 455313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
    Togni P; Sessa C; Varini M; Cavalli F
    Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.
    De Wasch G; Bernheim J; Michel J; Lejeune F; Kenis Y
    Cancer Treat Rep; 1976 Sep; 60(9):1273-6. PubMed ID: 65222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
    Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
    Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.